Atomoxetine (Strattera registered ) Exposure in Children

Atomoxetine uses a novel nonstimulant approach to the treatment of attention-deficit/hyperactivity disorder (ADHD) and is pharmacologically unrelated to other therapies used for ADHD, such as methylphenidate or clonidine. There have been no reports of overdose of atomoxetine in children or adults.

Saved in:
Bibliographic Details
Published in:Journal of toxicology. Clinical toxicology 2004-08, Vol.42 (5), p.720-720
Main Authors: Spiller, HA, Lintner, C P, Winter, M L
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atomoxetine uses a novel nonstimulant approach to the treatment of attention-deficit/hyperactivity disorder (ADHD) and is pharmacologically unrelated to other therapies used for ADHD, such as methylphenidate or clonidine. There have been no reports of overdose of atomoxetine in children or adults.
ISSN:0731-3810